Yuan, Irene
Katari, Priya
Shaker, Marcus
Article History
Received: 28 September 2018
Accepted: 14 May 2019
First Online: 25 June 2019
Ethics approval and consent to participate
: This case report is exempt from Institutional Review Board (IRB) review.
: The patient and his parent provided consent for this report. Written informed consent was obtained from the patient and legal guardian for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: Dr Shaker has a family member who is CEO of Altrix Medical and is a member of the Joint Task Force on Allergy Practice Parameters (AAAAI/ACAAI). Dr Katari and Ms Yuan have no conflicts of interest to declare.